P rogesterone (P4) is a multifunctional female sex hormone that promotes the development of mammary glands, ovulation, implantation of embryos, and maintenance of pregnancy (1). P4 is produced by granulosa cells and corpus luteum in the ovary. During pregnancy, the placenta becomes a major organ for P4 production. P4 can be produced also by cord blood (CB) erythroblasts and is present at high levels in CB (2, 3). Although the mechanism is still unclear, P4 is implicated in dampening immune responses to fetal and maternal Ags (4). P4 is metabolized into 17-hydroxyprogesterone, which can eventually be converted into other nuclear hormones including glucocorticoids, testosterone, and estradiol (5). P4 or its metabolic derivatives work through a number of different receptors. These include nuclear progesterone receptors (PR-A, PR-B, and PR-C), membrane progestin receptors (mPRa, mPRb, and mPRg), progesterone receptor membrane component-1 and -2, and glucocorticoid receptor (6-11). It has been documented that PRs and mPRs are expressed by T cells (10, 12, 13) . 
Progesterone, a key female sex hormone with pleiotropic functions in maintenance of pregnancy, has profound effects on regulation of immune responses. We report in this work a novel function of progesterone in regulation of naive cord blood (CB) fetal T cell differentiation into key T regulatory cell (Treg) subsets. Progesterone drives allogeneic activation-induced differentiation of CB naive, but not adult peripheral blood, T cells into immune-suppressive Tregs, many of which express FoxP3. Compared with those induced in the absence of progesterone, the FoxP3 + T cells induced in the presence of progesterone highly expressed memory T cell markers. In this regard, the Treg compartment in progesterone-rich CB is enriched with memory-type FoxP3 + T cells.
Moreover, CB APCs were more efficient than their peripheral blood counterparts in inducing FoxP3 + T cells. Another related function of progesterone that we discovered was to suppress the differentiation of CB CD4 + T cells into inflammation-associated Th17 cells. Progesterone enhanced activation of STAT5 in response to IL-2, whereas it decreased STAT3 activation in response to IL-6, which is in line with the selective activity of progesterone in generation of Tregs versus Th17 cells. Additionally, progesterone has a suppressive function on the expression of the IL-6 receptor by T cells. The results identified a novel role of progesterone in regulation of fetal T cell differentiation for promotion of immune tolerance. The Journal of Immunology, 2011, 187: 1778-1787.
P rogesterone (P4) is a multifunctional female sex hormone that promotes the development of mammary glands, ovulation, implantation of embryos, and maintenance of pregnancy (1) . P4 is produced by granulosa cells and corpus luteum in the ovary. During pregnancy, the placenta becomes a major organ for P4 production. P4 can be produced also by cord blood (CB) erythroblasts and is present at high levels in CB (2, 3) . Although the mechanism is still unclear, P4 is implicated in dampening immune responses to fetal and maternal Ags (4) . P4 is metabolized into 17-hydroxyprogesterone, which can eventually be converted into other nuclear hormones including glucocorticoids, testosterone, and estradiol (5) . P4 or its metabolic derivatives work through a number of different receptors. These include nuclear progesterone receptors (PR-A, PR-B, and PR-C), membrane progestin receptors (mPRa, mPRb, and mPRg), progesterone receptor membrane component-1 and -2, and glucocorticoid receptor (6) (7) (8) (9) (10) (11) . It has been documented that PRs and mPRs are expressed by T cells (10, 12, 13) .
T regulatory cells (Tregs) are heterogeneous and are functionally defined by their suppressive function on non-Tregs. Tregs can be classified into natural Tregs and induced Tregs (iTregs).
Some Tregs coexpress FoxP3 and CD25 and have been studied extensively. Tregs play important roles in suppression of inflammatory and autoimmune responses (14) (15) (16) (17) . FoxP3 + Tregs are increased during pregnancy in both maternal and fetal systems in response to allogeneic Ags (18, 19) . TGF-b1 and IL-2 play central roles in induction of induced FoxP3 + (iFoxP3 + ) Tregs (20) (21) (22) . Fetal T cells have an increased propensity to differentiate into Tregs in a TGF-b1-dependent fashion (23, 24) , and fetal T cell progenitor cells can more efficiently make Tregs compared with adult progenitor cells (25) . STAT5 A/B are involved in the IL-2-dependent induction of FoxP3 + T cells but restrain the generation of Th17 cells (26, 27) . Th17 cells are defined by their ability to produce IL-17 and are associated with immune responses to extracellular pathogens and tissue-specific autoimmune diseases (28, 29) . Th17 cells are mostly induced in the periphery from naive T cells upon Ag priming. It has been well established that inflammatory cytokines such as IL-6, IL-23, IL-1b, and TNF-a promote the generation of Th17 cells during Ag priming (30) . Transcription factors, such as STAT3, RORgt, RORa, and aryl hydrocarbon receptor, are implicated in Th17 cell development (28, (30) (31) (32) .
Because P4 is greatly increased in CB and fetal circulation and plays important roles in suppression of immune responses, we investigated the possibility that P4 is actively involved in generation of Tregs and Th17 cells from CB naive T cells. Our study revealed novel functions of P4 in regulation of immune responses. P4 induces naive CB T cell differentiation into immune-suppressive Tregs, but it suppresses their differentiation into inflammatory Th17 cells. Notably, the P4-mediated induction of Tregs efficiently occurs with CB naive T cells but not with adult peripheral blood (PB) T cells. We provide potential mechanisms involving STAT3/5 proteins and IL-6R in selective regulation of CB T cell differentiation. Potential effects of this regulatory pathway on establishment of immune tolerance are discussed.
Materials and Methods

Preparation of cells
Mononuclear cells were prepared by density gradient centrifuge on Histopaque 1077 (Sigma-Aldrich, St. Louis, MO) from human CB and adult PB as described previously (33 
CD56
2 CB or adult PB mononuclear cells were used after irradiation (2000 rad). The use of human CB and PB for this study was approved by the Institutional Review Board at Purdue University.
In vitro T cell differentiation in response to P4
Neonatal CB and adult PB naive CD4 + T cells were activated with one of the T cell activators including anti-CD3-and anti-CD28-coated beads (5 ml/million cells; Miltenyi Biotec), PHA (5 mg/ml), or irradiated CD3
2
CD56
2 allogeneic PB or CB mononuclear cells as APCs for 6-7 d. IL-2 (25 U/ml) was added for generation of Tregs. All experiments were performed with phenol red-free RPMI 1640 medium supplemented with charcoal/dextran-treated FBS (10%; HyClone). Depending on the activity of each batch, TGF-b1 was used in the concentration range from 25 to 500 Table I . For induction of Th17 cells, CB naive CD4 + T cells were activated with anti-CD3/CD28 beads (Miltenyi Biotec) for 6-7 d in RPMI 1640 medium supplemented with FBS (10%), IL-23 (25 ng/ml; R&D Systems), IL-1b (10 ng/ml; PeproTech, Rocky Hill, NJ), TGF-b1 (1 ng/ml; PeproTech), anti-IL-4 (10 mg/ml; MP4-25D2; BioLegend), and anti-IFN-g (10 mg/ml; MD-1; BioLegend). P4 was added at 2 mg/ml from the beginning of the culture. T cells were stained with anti-CD4 (RPA-T4) and then activated with PMA (50 ng/ml) and ionomycin (1 mM) for 4 h in the presence of monensin (2 mg/ml) before staining with Abs to IL-17 and IFN-g as previously described (35) .
Flow cytometry to determine surface Ag phenotype and STAT phosphorylation 
Impact of P4 on T cell differentiation into iTregs in the presence of IL-6
Human CB naive cells were activated with anti-CD3/CD28 beads together with or without P4 (2 mg/ml) in RPMI 1640 medium containing charcoal/ dextran-treated FBS (10%), hIL-2 (25 U/ml), and TGF-b1 for 6-7 d. hIL-6 and/or anti-IL-6R neutralizing Ab (MAB227, 10 mg/ml) were added to the culture. The cultured cells were harvested and stained with anti-human CD4, anti-human CD25, and anti-human FoxP3 Abs. The expression of FoxP3 was determined by Canto II.
Immunofluorescence staining and confocal microscopy
The cultured T cells were stained with Abs for surface CD4 (clone RPA-T4) and intracellular FoxP3 (clone 236A/E7). The cells were cytospun on slide glasses, and the expression of surface CD4 and nuclear FoxP3 was documented by confocal microscopy (Zeiss LSM 710).
Microarray gene expression analysis
Human CB and PB naive T cells were cultured for 5 d with anti-CD3/CD28 beads (Miltenyi Biotec) in the presence or absence of P4 (2 mg/ml) and/or Combined data from three to four experiments are shown. *Significant differences from the respective control groups (no P4).
TGF-b1 (150 pg/ml) in the RPMI 1640 medium supplemented with charcoal/dextran-treated FBS (10%) and hIL-2 (25 U/ml). The cultured cells were harvested, and the total RNA was isolated using RNeasy kit (Qiagen). Total RNA, isolated from the cultured CD4 + T, was hybridized to Human Genome U133 Plus 2.0 Array chips (Affymetrix) by Purdue Genomics Laboratory. These arrays contain .54,000 cDNA spots corresponding with human sequence-verified transcripts. Raw intensity values were obtained with the GCOS software (Affymetrix) and normalized with the expression values of a housekeeping gene (GAPDH). Selection and filtering of high-quality genes were based on a 2-fold or greater differential in expression up or down between two conditions of comparison. Further selection was based on reproducibility between technical replicates, and transcripts without consistent results or with signal intensity ,50 were dismissed. The gene expression values were visualized with the multiplot module of the GenePattern genomic analysis platform (http://www.broad. mit.edu/cancer/software/genepattern) and the TreeView module from EisenSoftware (http://rana.lbl.gov/EisenSoftware.htm). The raw and processed array data have been deposited in the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE22025.
Real-time PCR analysis of mRNA expression cDNA was made and real-time quantitative PCR was performed on a 7300 Sequence Detection System (Applied Biosystems, Foster City, CA) using the SYBR Green Master Mix (Applied Biosystems) as described previously (36) . Normalized expression was calculated based on threshold cycle values with b-actin used as an internal control. The primers used for realtime PCR are shown in Supplemental Table I .
Statistical analysis
All experiments were performed multiple times to confirm their reproducibility. For combined data from multiple experiments, Student paired two-tailed t test was used, and p values #0.05 were considered significant. For combined data, the error bars are SEM. For the data that are difficult to combine, representative data are shown with error bars showing differences between duplicated measurements.
Results
P4 promotes the differentiation of human CB naive T cells into Tregs with a highly regulatory function
To determine if P4 enhances FoxP3 + Treg differentiation, CB naive T cells were activated in the presence or absence of P4. We supplemented the culture with TGF-b1 at a minimally active concentration, which is known to induce iFoxP3 + T cells. P4 had a positive effect on generation of iFoxP3 + T cells (Fig. 1A) . The FoxP3 induction in response to P4 occurred also in the absence of exogenous TGF-b1 in some experiments, but it was more reliable and efficient in the presence of TGF-b1. The FoxP3 protein expressed in response to P4 was localized to the nuclei of T cells as expected (Fig. 1B) . The effect of P4 was a dose-dependent one, peaking at around 2 mg/ml P4 (Fig. 1C) .
It has been reported that induced human FoxP3 + T cells with TGF-b1 lack the suppressive activity characteristic for Tregs (37) . Therefore, simple induction of FoxP3 appears not sufficient to make human T cells into Tregs, which is better defined functionally. (Fig. 1D) . RU486, an antagonist for several different PRs, fully suppressed the P4-induced expression of the FoxP3 protein and transcription of the FoxP3 gene (Fig. 1E, 1F ).
Adult PB naive T cells are resistant to P4-induced conversion into FoxP3 + T cells
It has previously been reported that CB is a better source of Treg progenitors compared with PB (38) . We examined if CB T cells are different from PB T cells in response to P4. Compared with the highly sensitive CB T cells, adult PB naive T cells were largely unresponsive to P4 (Fig. 2A) .
To determine if P4 can selectively promote the induction of FoxP3 + T cells from CB versus PB naive T cells during allogeneic responses between T cells and APCs, we cocultured naive CD4 + T cells and irradiated T cell-depleted allogeneic CB or PB mononuclear cells isolated from different individuals (Fig. 2B) . P4 significantly increased the induction of FoxP3 + T cells during the allogeneic priming of CB T cells. In contrast, adult PB naive T cells were again poorly responsive. CB APCs were more potent than adult APCs in induction of P4-induced FoxP3 + T cells (Fig. 2B) . Next, we asked if CB naive T cells would remain responsive to P4 even after previous Ag priming events. To address this, CB T cells were cultured first with or without P4 and then recultured with P4 and/or TGF-b1 (Fig. 3) . P4 was unable to induce FoxP3 expression once the CB naive T cells were preactivated. Initial exposure to P4 was critical to induce FoxP3 + T cells at high levels by P4 upon subsequent activation with TGF-b1 alone or P4 and TGF-b1. Three days of initial P4 exposure was sufficient to induce this effect. The results suggest that CB T cells indeed lose the ability to respond to P4 and TGF-b1 if they are previously activated in the absence of P4.
P4-induced iFoxP3
+ T cells are related to the memory-type natural CB FoxP3 + T cells
Human CB CD4 + T cells, although known to be mostly composed of naive cells, contain a significant memory (CD45RA 2   CD45RO   +   ) cell population, suggesting a history of ongoing Ag-priming events in fetuses (Fig. 4A ). This can be induced preferentially by allogeneic immune responses between fetal T cells and maternal APCs or fetal APCs presenting maternal Ags. Notably, 30-40% of these memory T cells were FoxP3 + T cells (Fig. 4A, 4B ). This is considered very high compared with the low frequency (∼10%) of FoxP3 + T cells among adult PB memory T cells (Fig.  4B) (Fig. 4A) . These results suggest that many CB FoxP3 + T cells may have been Ag-primed and assumed the memory T cell phenotype. These memory-type CB FoxP3 + T cells expressed CD49f (integrin a6) and CD58 (LFA-3), the Ags typically associated with Ag-primed T cells (Fig. 4C) 2 cells (Fig. 5A ), and this phenotype is similar to the memory-type FoxP3 + T cells naturally present in CB (Fig. 4) . In contrast, the T cells Ag-primed without exogenous P4 (but in the presence of TGF-b1) were mostly T cells of intermediary CD45RO
2
CD45RA
2 phenotype, suggesting that P4 has a profound regulatory effect on expression of the naive and memory cell-associated Ags as well. Moreover, P4-induced FoxP3 + T cells were higher than control iFoxP3 + T cells in expression of CTLA4 and CD69, but lower in expression of by guest on April 17, 2017 http://www.jimmunol.org/ Downloaded from CD45RB and CD62L, a feature consistent with recently activated memory FoxP3 + T cells (Fig. 5B) . Expression of another Tregassociated molecule, 4-1BB, was somewhat decreased on these cells compared with that on control iFoxP3 + T cells.
P4 suppresses the generation of Th17 cells
Th17 cells and FoxP3 + T cells, although very different in their functions, are related in their differentiation. Both of the populations are induced by TGF-b1. However, they are different in that IL-2 promotes FoxP3 + T cells and suppresses Th17 cell differentiation, whereas inflammatory cytokines such as IL-6 that induce Th17 cells suppress FoxP3 + T cell development. We therefore examined if P4 has any role in differentiation of CB T cells into Th17 cells in response to inflammatory cytokines. For this, we cultured naive CB CD4 + T cells in a Th17 cell induction condition in the presence and absence of P4. P4 dramatically reduced the conversion of naive T cells into Th17 cells (Fig. 6A) . The effect of P4 is similar to that of retinoic acid, which is known to suppress Th17 cells. Along with IL-17A, expression of Th17 cell-associated IL-17F, IL-21, and RORC transcripts was decreased by P4 (Fig. 6B) . Although not statistically significant, other genes such as IL-23R, STAT3, AHR, and CCR6 were decreased, too. Expression of IL-22, however, was not suppressed by P4.
Potential mechanisms for P4 regulation of T cell differentiation through modulation of STAT5, STAT3, and IL-6R
STAT5 A/B proteins are key molecules that regulate T cell differentiation into FoxP3 + T cells and Th17 cells. Activation of STAT5 by IL-2 promotes the generation of FoxP3
+ T cells at the expense of Th17 cells. We found that P4 increases the phosphorylation of STAT5 A/B in the CB T cells induced by IL-2 (Fig.   7A ). P4 by itself, however, did not induce phosphorylation of STAT5 A/B. We examined also the activation of STAT3 because this molecule is central to transmission of signals to induce Th17 cells and suppress Tregs. Upon stimulation with IL-6, T cells cultured with P4 had decreased phosphorylation of STAT3 compared with that of the T cells cultured in the absence of P4 (Fig.  7B) . Thus, these results show that STAT3 and STAT5 are downstream targets of P4 for regulation of FoxP3 + T cells and Th17 cells.
To gain more insights into the P4 regulation of T cell differentiation, we examined the global gene expression pattern of CB T cells regulated by P4. We found 325-347 genes upregulated or downregulated by P4 either in the presence or absence of exogenous TGF-b1 (Fig. 8A, Supplemental Fig. 1A, 1B) . PB T cells were relatively unresponsive with only 30-70 genes regulated by P4. IL-6R expression was greatly downregulated by P4 in CB, but not PB, T cells (Fig. 8A) . IL-6R mediates the IL-6 signal, which suppresses the induction of FoxP3 + T cells but enhances the induction of Th17 cells (39, 40) . We confirmed that IL-6R mRNA and protein are decreased by P4 (Fig. 8B, 8C) . Consistently, iFoxP3 + T cells were made even in the presence of IL-6 when P4 was added to the culture (Fig. 8D) . Also, the decrease in IL-6R expression by P4 accounts for the decreased induction of Th17 cells in response to IL-6 (Fig. 8E) .
The following genes regulated by P4 have been verified by realtime PCR (Supplemental Fig. 1C ): growth factor independent 1 transcription repressor (GFI1, a suppressor of Th17 cell induction) (41), ankyrin repeat and SOCS box-containing 2 (ASB2, a regulator for degradation of SOCS proteins) (42), CD38 (a cyclic ADP ribose hydrolase), EBI3 (the common subunit of IL-27 and IL-35), TNFSF13B (also called BAFF or BLyS), leucine zipper transcription factor-like 1 (LZTFL1) (43), methyltransferase like 7A (METTL7A), hypermethylated in cancer 1 protein (HIC1), growth factor independent 1 transcription repressor (GFI1) (44), SOCS1, SOCS2, SOCS3, CCL5, 29,59-oligoadenylate synthetase 1 (OAS1), and IFN-induced protein with tetratricopeptide repeats 3 (IFIT3). Among these, SOCS1 and SOCS2 were downregulated, whereas others were upregulated. A more extensive list can be found in Supplemental Fig. 1B .
Discussion
In this study, we investigated the P4 effect on CB fetal T cell differentiation into immune-suppressive Tregs and inflammatory Th17 cells. Through the study, we gained novel information regarding the function of P4 in regulation of T cell differentiation. First, we found that P4 has a positive effect on human naive T cell differentiation into Tregs expressing FoxP3. Notably, CB T cells were highly responsive to P4 in this process, whereas adult PB T cells were largely unresponsive to P4. Second, whereas P4 promotes the differentiation of naive T cells into FoxP3 + T cells, P4 has an inhibitory effect on CB T cell differentiation into Th17 cells. P4 acts on neonatal T cells undergoing Ag priming and changes their gene expression program to steer the T cell differentiation into tolerogenic Tregs but suppresses the generation of potentially inflammatory effector T cells.
Several studies have proposed the link between nuclear hormones and FoxP3 + T cells. The best-studied example to date is the role of retinoic acid in induction of FoxP3 + T cells (34, (45) (46) (47) . Retinoic acid by itself is a weak inducer of FoxP3 + T cells but has a potent enhancing effect on TGF-b1-induced generation of FoxP3 + T cells. Reciprocally, retinoic acid has a suppressive effect on generation of Th17 cells. Also, P4 is implicated in induction and expansion of CD4 + CD25 + Tregs in the uteruses of pregnant mice (48) . Others reported that Tregs were decreased in the circulation of pregnant females and proposed that P4 may negatively regulate T cell conversion into Tregs (49) . This study, however, failed to determine the direct effect of P4 on Treg-depleted naive T cells and, thus, appears to be inconclusive. Also, the circulating Tregs may not faithfully represent the Tregs that are induced in response to P4 in specific tissues. Other nuclear hormones that are implicated in induction or expansion of Tregs are estrogen and vitamin D (50, 51) . Therefore, nuclear hormone receptors as a group appear to play important roles in induction of immune tolerance.
Separate from the function of P4, we observed that APCs of CB provide signals conducive for generation of Tregs. When CB T cells are Ag-primed by allogeneic APCs, CB APCs are significantly more efficient than PB APCs in inducing FoxP3 + T cells. All of the characteristics of CB T cells and APCs would work together to make the immune responses induced by CB cells more tolerogenic and less inflammatory.
Our results have implications in a number of biological processes. One important process is regulation of immune responses and T cell differentiation during fetal development. The serum concentration of P4 at near-term pregnancy can reach ∼150 ng/ml in maternal circulation, ∼400 ng/ml in CB, and 300-3000 ng/ml in the human placental tissue (3, 52) . Thus, up to ∼3000 ng/ml P4 is considered within the physiological concentration range. Importantly, the doses of P4 that we used in this study are within this range. The P4-treated T cells were more suppressive than control iTregs induced with TGF-b1, and this suggests that P4 fundamentally changes the function of most T cells beyond induction of FoxP3 expression in some cells. P4 has the potential to suppress T cell responses in both pregnant females and fetuses. The difficulty of adult T cells to become Tregs in response to P4, however, suggests that the P4 function is more important in fetuses and newborns than in pregnant females. Therefore, a hypothetical role for P4-induced induction of Tregs and suppression of Th17 cells is to promote immune tolerance in the early life.
We identified increased STAT5 activation and decreased STAT3 activation and IL-6R expression by P4 as potential mechanisms for the P4-regulated differentiation of T cells. STAT5 activation in response to IL-2 promotes T cell differentiation into FoxP3 + T cells but restrains the process of differentiation into Th17 cells. IL-6R, of course, is essential to receive the IL-6 signal, which is, in contrast to IL-2 and STAT5, a major signal to shift T cell differentiation toward the generation of Th17 cells away from FoxP3 + T cells. In this regard, it has been reported that P4 induces the expression and activation of STAT5 in breast cells (53, 54) . STAT3 is a central player in delivering the signals from IL-6 and IL-23 in generation of Th17 cells and suppression of Tregs. Therefore, dampened activation of STAT3 in conjunction with enhanced activation of STAT5 would make the cell signaling system conducive to generation of Tregs and suppress Th17 cell development. It may not be just coincidental that decreased IL-6R is linked to retinoic acid-mediated regulation of T cell differentiation in mice as well (55) . It appears that there are common mechanisms for the action of nuclear hormone receptor ligands in regulation of T cell differentiation. In addition to STAT3/5 and IL-6R, additional genes and molecules are likely to be involved in the regulation of fetal T cells by P4. In this regard, we identified many genes that are regulated by P4 through a genome-wide microarray study.
The results of the genome-wide microarray study show the differential responses between CB and PB T cells in response to P4. CB T cells were highly responsive in upregulating or downregulating genes, whereas PB T cells did not significantly change their gene expression program in response to P4. It would be interesting to study in the future how the genes in CB and PB T cells are differentially regulated at the molecular level. Among the genes upregulated with P4, TNFSF13B/BAFF is known to expand CD4 + CD25 + Foxp3 + Tregs (56) . EBI3, a subunit of IL35 and induced by P4, is a key effector cytokine of Tregs to suppress target cells (57, 58) . SOCS1, which negatively regulates Tregs (59), was decreased by P4. CD38, important for homeostasis of Tregs through regulation of NAD (60) , was increased by P4. Some of the genes such as OAS1, RGS1, and TNFSF13B, highly induced in response to P4, were among the genes induced in Tregs derived from fetal stem and progenitor cells (25) . The roles of the P4-regulated molecules in control of T cell differentiation and function remain to be determined. P4 :
